Although the 13C-urea breath test is commonly used for detection of Helicobacter pylori infection and eradication, access to commercial testing centres for analysis may at times limit its use.
We have addressed this issue by establishing a regional-based means of analysis as a Hospital-University collaboration.
A blind comparison was undertaken of 13C-urea breath test results performed'in house'by the stable isotope laboratory in Queen's University Belfast and a commercially available 13C-urea breath test.
The H. pylori status of the patients (n=110) agreed for all patients (kappa score=1).
The excess values showed good agreement.
The cost of the'in house'breath test was less than £20 compared with £32.90 for the commercial breath test.
Regional access to the 13C-urea breath test could decrease costs, increase availability of testing, improve local health services and economy and increase collaborative research opportunities.
Mots-clés Pascal : Gastrite, Campylobactériose, Bactériose, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bactérie, Diagnostic, Test respiratoire, Urée, Technique, Hôpital, Ambulatoire, Etude comparative, Faisabilité, Efficacité, Coût, Résultat, Homme, Appareil digestif pathologie, Estomac pathologie, Economie santé
Mots-clés Pascal anglais : Gastritis, Campylobacter infection, Bacteriosis, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bacteria, Diagnosis, Breath test, Urea, Technique, Hospital, Ambulatory, Comparative study, Feasibility, Efficiency, Costs, Result, Human, Digestive diseases, Gastric disease, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0428855
Code Inist : 002A05B14. Création : 19/12/1997.